0000950123-19-005104.txt : 20190515 0000950123-19-005104.hdr.sgml : 20190515 20190515090246 ACCESSION NUMBER: 0000950123-19-005104 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 EFFECTIVENESS DATE: 20190515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Fund, L.P. CENTRAL INDEX KEY: 0001687968 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-18478 FILM NUMBER: 19825316 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-516-2000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml 13F-NT LIVE false true false 0001687968 XXXXXXXX 03-31-2019 03-31-2019 Bain Capital Life Sciences Fund, L.P.

200 Clarendon Street Boston MA 02116

13F NOTICE 028-18478 28-18477 Bain Capital Life Sciences Investors, LLC 28-18476 Bain Capital Life Sciences Partners, LP Y The report on Form 13F for the period ended March 31, 2019 for Bain Capital Life Sciences Fund, L.P. (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of the Fund. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 05-15-2019